LEOBENDORF, Austria,
April 29, 2019 /PRNewswire/ -- Croma,
short for CROMA-PHARMA GmbH, strives for innovation in
order to maximize its customers' and patients' well-being.
Therefore in May 2019
Croma proudly introduces threadz® – the
outstanding newcomer in minimally invasive aesthetic medicine.
threadz® is one of the first PDO sutures for tissue
elevation that has been registered according to the existing
Medical Device Law. The safety and efficacy performance of the
product has been verified during the successful conformity
assessment procedure, allowing Croma to offer threadz®
for minimally invasive tissue elevation.
threadz® is the result of a long and comprehensive
development process embracing science, knowledge, and
expertise.
Croma is committed to high quality standards, thus
threadz® are produced by a U.S. manufacturer with
over 40 years of experience, trusted for its quality in development
and production of surgical devices. Croma designed
threadz® in close collaboration with experienced
healthcare professionals and optimized the product according to
their needs and requirements to increase efficacy and patients´
satisfaction. Therefore the product includes unique,
registered, gloves friendly, comfortable grip hub with ergonomic
shape and specially coated thin-wall needle/cannula for better
glide for smooth and easy application.
Healthcare professionals can discover convenience, simplicity,
and the efficacy of the new product, which is available in 3
subtypes:
- threadz® plain – unmodified monofilament housed
in needle for delicate fixation of the thin skin in some areas
(e.g. periorbital).
- threadz® screw – spiral configuration of the
suture housed in needle for better fixation in the tissues.
- threadz® barbed – sutures with bi-directional
helically 3D oriented barbs, housed either on needle or cannula for
stronger repositioning effect.
To offer the optimal freedom of choice, these subtypes are
available in different sizes. Doctors can choose the most
appropriate suture for different anatomical zones and address
individual patients' needs in a best possible way.
Croma is proud of its wide portfolio of PDO sutures
for minimally invasive skin elevation. Additionally to the newly
released threadz® range, Croma still offers its
most popular product of Princess® Threads line:
Princess® Threads Barb II Anchor – with "cold pressed
& sculptured" arrow shaped cogs for ultimate elevation
effect.
About Croma-Pharma GmbH
Founded in 1976, Croma-Pharma GmbH (Croma) is an Austrian
family-owned company that specializes in the industrial production
of hyaluronic acid syringes for the fields of medical aesthetics,
ophthalmology and orthopaedics. Croma currently runs 12
international sales companies and distributes its products in more
than 70 countries.
Within its global sales network, Croma focuses with own branded
products on minimally invasive aesthetic medicine. Besides a broad
range of HA fillers from the own production site, Croma markets PDO
lifting threads, a Platelet Rich Plasma (PRP) system and a
personalized skincare technology in its core strategic markets.
Contact
CROMA-PHARMA GmbH
Mag. Stefanie Höhn
Corporate Director Communications
Cromazeile 2
A-2100 Leobendorf
Phone .: +43 676 846868 190
Mail: stefanie.hoehn@croma.at
Home: www.croma.at